GWM Advisors LLC Takes $667,000 Position in Innovator IBD 50 ETF (NYSEARCA:FFTY)

GWM Advisors LLC bought a new position in Innovator IBD 50 ETF (NYSEARCA:FFTY) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 19,911 shares of the company’s stock, valued at approximately $667,000. GWM Advisors LLC owned 0.15% of Innovator IBD 50 ETF as of its most recent filing with the SEC.

A number of other institutional investors have also recently modified their holdings of the stock. Commonwealth Equity Services LLC raised its position in Innovator IBD 50 ETF by 334.0% in the 1st quarter. Commonwealth Equity Services LLC now owns 390,988 shares of the company’s stock worth $13,105,000 after purchasing an additional 300,906 shares during the period. Resources Investment Advisors Inc. purchased a new position in shares of Innovator IBD 50 ETF during the first quarter worth approximately $538,000. Sawtooth Solutions LLC purchased a new position in shares of Innovator IBD 50 ETF during the first quarter worth approximately $432,000. Wells Fargo & Company MN increased its position in shares of Innovator IBD 50 ETF by 191.8% during the first quarter. Wells Fargo & Company MN now owns 967,250 shares of the company’s stock worth $32,422,000 after acquiring an additional 635,726 shares during the period. Finally, CIBC World Markets Inc. purchased a new position in shares of Innovator IBD 50 ETF during the first quarter worth approximately $989,000.

Shares of NYSEARCA:FFTY traded down $0.01 during trading on Friday, reaching $35.14. 131,057 shares of the company were exchanged, compared to its average volume of 235,343. The business’s fifty day simple moving average is $33.57. Innovator IBD 50 ETF has a 12-month low of $25.39 and a 12-month high of $38.79.

Recommended Story: Conference Calls and Individual Investors

Institutional Ownership by Quarter for Innovator IBD 50 ETF (NYSEARCA:FFTY)

Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.